Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Technology appraisal guidance
Reference number: TA355
Published: 23 September 2015
Last updated: 02 July 2021

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: final appraisal determination document

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: final appraisal determination document

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: final appraisal determination document
06 August 2015
(427.43 Kb 4 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 04 August 2015